B. J. Deacon, The biomedical model of mental disorder: a critical analysis of its validity, utility, and effects on psychotherapy research, Clin Psychol Rev, vol.33, issue.7, pp.846-61, 2013.

A. Testa, R. Giannuzzi, S. Daini, L. Bernardini, L. Petrongolo et al., Psychiatric emergencies (part III): psychiatric symptoms resulting from organic diseases, Eur Rev Med Pharmacol Sci, vol.17, issue.1, p.23436670, 2013.

J. K. Talbot-stern, T. Green, and T. J. Royle, Psychiatric manifestations of systemic illness, Emerg Med Clin North Am, vol.18, issue.2, p.10767878, 2000.

R. C. Hall, M. K. Popkin, R. A. Devaul, L. A. Faillace, and S. K. Stickney, Physical illness presenting as psychiatric disease. Arch Gen Psychiatry, vol.35, p.568461, 1978.

E. C. Johnstone, J. F. Macmillan, and T. J. Crow, The occurrence of organic disease of possible or probable aetiological significance in a population of 268 cases of first episode schizophrenia, Psychol Med, vol.17, issue.2, pp.371-380, 1987.

R. R. Reeves, E. J. Pendarvis, and R. Kimble, Unrecognized medical emergencies admitted to psychiatric units, Am J Emerg Med, vol.18, issue.4, p.10919525, 2000.

, Haute Autorité de Santé -Guide -Affection Longue Durée -Affections psychiatriques de longue durée Troubles dépressifs récurrents ou persistants de l'adulte. Février, 2009.

, Recommandation de bonne pratique en psychiatrie : Comment améliorer la prise en charge somatique des patients ayant une pathologie psychiatrique sévère et chronique, Recommandations Juin, 2015.

A. A. Nierenberg and J. D. Amsterdam, Treatment-resistant depression: definition and treatment approaches, Review. PubMed PMID, vol.51, p.2112132, 1990.

G. Decaux, Is asymptomatic hyponatremia really asymptomatic?, Am J Med, vol.119, issue.7, pp.79-82, 2006.

J. C. Felger, E. Haroon, T. A. Patel, D. R. Goldsmith, E. C. Wommack et al., What does plasma CRP tell us about peripheral and central inflammation in depression? Mol Psychiatry, 2018.

S. Gilbody, T. Lightfoot, and T. Sheldon, Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity, J Epidemiol Community Health, vol.61, issue.7, p.17568057, 2007.

X. Huang, Y. Fan, X. Han, Z. Huang, M. Yu et al., Association between Serum Vitamin Levels and Depression in U.S. Adults 20 Years or Older Based on National Health and Nutrition Examination Survey, Int J Environ Res Public Health, vol.15, issue.6, 2009.

T. G. Issac, S. Soundarya, R. Christopher, and S. R. Chandra, Vitamin B12 deficiency: an important reversible comorbidity in neuropsychiatric manifestations, Indian J Psychol Med, vol.37, issue.1, pp.26-35, 2015.

S. Mouchabac and . Homocystéine, Neuropsychiatrie : Tendances et Débats, vol.32, pp.9-18, 2008.

B. M. Cohen, B. R. Sommer, and A. Vuckovic, Antidepressant-Resistant Depression in Patients With Comorbid Subclinical Hypothyroidism or High-Normal TSH Levels, Am J Psychiatry, vol.175, issue.7, pp.598-604, 2018.

G. Schoretsanitis, M. Paulzen, S. Unterecker, M. Schwarz, A. Conca et al., TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, World J Biol Psychiatry, vol.19, issue.3, pp.162-174, 2017.

S. Quaranta, J. Dupouey, R. Colle, and C. Verstuyft, Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation -recommendations from the French National Network of Pharmacogenetics, Therapie

, , vol.72, pp.311-318

C. Tessier, K. Sweers, A. Frajerman, H. Bergaoui, F. Ferreri et al., Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations, Transl Psychiatry, vol.6, issue.10, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01380206

D. M. Kasote, M. V. Hegde, and S. S. Katyare, Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy, Biofactors, vol.39, issue.4, pp.392-406, 2013.

V. Ferrafiat, M. Raffin, E. Freri, T. Granata, N. Nardocci et al., A causality algorithm to guide diagnosis and treatment of catatonia due to autoimmune conditions in children and adolescents, Schizophr Res, issue.17, pp.30375-30379, 2017.

O. Bonnot, H. H. Klünemann, F. Sedel, S. Tordjman, D. Cohen et al., Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review, Orphanet J Rare Dis, vol.9, p.65, 2014.

N. Warren, D. Siskind, O. 'gorman, and C. , Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis, Acta Psychiatr Scand, 2018.

D. W. Kimberlin, Management of HSV encephalitis in adults and neonates: diagnosis, prognosis and treatment, Herpes, vol.14, issue.1, 2007.

J. Noblett and E. Roberts, The importance of not jumping to conclusions: syphilis as an organic cause of neurological, psychiatric and endocrine presentations, BMJ Case Rep, p.2014207900, 2015.

E. H. Seo, H. J. Yang, S. H. Kim, J. H. Park, and H. J. Yoon, Psychotic mania as the solitary manifestation of neurosyphilis

A. G. Psychiatry, , vol.17, p.24, 2018.

A. Alciati, A. Fusi, D. Monforte, A. Coen, M. Ferri et al., New-onset delusions and hallucinations in patients infected with HIV, J Psychiatry Neurosci, vol.26, issue.3, p.11394192, 2001.

B. A. Fallon, J. A. Nields, B. Parsons, M. R. Liebowitz, and D. F. Klein, Psychiatric manifestations of Lyme borreliosis, J Clin Psychiatry, vol.54, issue.7, p.8335653, 1993.

F. Blanc, B. Abdelghani, K. Schramm, F. Jaulhac, B. Chatelus et al., Whipple limbic encephalitis, Arch Neurol, vol.68, issue.11, pp.1471-1474, 2011.

F. Graus, J. Y. Delattre, and J. C. Antoine, Recommended diagnostic criteria for paraneoplastic neurological syndromes, JNNP, vol.75, pp.1135-1175, 2004.

A. Venkatesan, A. R. Tunkel, K. C. Bloch, A. S. Lauring, J. Sejvar et al., Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium, Clin Infect Dis, vol.57, pp.1114-1142, 2013.

G. Lefèvre, H. Zéphir, E. Michelin, F. Semah, F. Warembourg et al.,

, Rev Med Interne, vol.33, issue.9, pp.503-516, 2009.

J. Y. Zhou, B. Xu, J. Lopes, J. Blamoun, and L. Li, Hashimoto encephalopathy: literature review, Acta Neurol Scand, vol.135, issue.3, pp.285-290, 2016.

R. A. Marrie, S. Reingold, J. Cohen, O. Stuve, M. Trojano et al., The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review, Mult Scler, vol.21, issue.3, pp.305-322, 2015.

N. K. Jamison and E. G. Holmes, A Case of Mast Cell Leukemia: A Review of the Pathophysiology of Systemic Mastocytosis and Associated Psychiatric Symptoms, Psychosomatics, issue.18, pp.30129-30133, 2018.

C. G. Lyketsos, M. C. Carrillo, J. M. Ryan, A. S. Khachaturian, P. Trzepacz et al., Neuropsychiatric symptoms in Alzheimer's disease. Alzheimers Dement, vol.7, pp.532-541, 2011.

D. Weintraub and M. B. Stern, Psychiatric complications in Parkinson disease, Am J Geriatr Psychiatry, vol.13, issue.10, pp.844-51, 2005.

C. G. Ballard, R. Jacoby, D. Ser, T. Khan, M. N. Munoz et al., Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies, Am J Psychiatry, vol.161, issue.5, pp.843-852, 2004.

A. Dols, S. Van-liempt, F. Gossink, W. A. Krudop, S. Sikkes et al., Identifying Specific Clinical Symptoms of Behavioral Variant Frontotemporal Dementia Versus Differential Psychiatric Disorders in Patients Presenting With a Late-Onset Frontal Lobe Syndrome, J Clin Psychiatry, vol.77, issue.10, pp.1391-1395, 2016.

J. A. Gold, Y. Sher, and J. R. Maldonado, Frontal Lobe Epilepsy: A Primer for Psychiatrists and a Systematic Review of Psychiatric Manifestations, Psychosomatics, vol.57, issue.5, pp.445-64, 2016.

L. Kandratavicius, C. Lopes-aguiar, L. S. Bueno-júnior, R. N. Romcy-pereira, J. E. Hallak et al., Psychiatric comorbidities in temporal lobe epilepsy: possible relationships between psychotic disorders and involvement of limbic circuits, Rev Bras Psiquiatr, 2012.

S. Madhusoodanan, M. B. Ting, T. Farah, U. Ugur, . World et al., , vol.5, pp.273-85, 2015.

R. E. Anglin, P. I. Rosebush, and M. F. Mazurek, The neuropsychiatric profile of Addison's disease: revisiting a forgotten phenomenon, J Neuropsychiatry Clin Neurosci, vol.18, issue.4, pp.450-459, 2006.

C. Alguire, J. Chbat, I. Forest, A. Godbout, and I. Bourdeau, Unusual presentation of pheochromocytoma: thirteen years of anxiety requiring psychiatric treatment. Endocrinol Diabetes Metab Case Rep, pp.17-0176, 2018.

V. Ramaekers, J. M. Sequeira, and E. V. Quadros, Clinical recognition and aspects of the cerebral folate deficiency syndromes, Clin Chem Lab Med, vol.51, issue.3, pp.497-511, 2013.

V. T. Ramaekers, J. M. Sequeira, and E. V. Quadros, The basis for folinic acid treatment in neuro-psychiatric disorders, Biochimie, vol.126, pp.79-90, 2016.

S. Mukku, S. Suhas, H. Thippeswamy, S. Ganjekar, A. Hr et al., Mixed neuropsychiatric clinical manifestations associated with vitamin B12 deficiency, Asian J Psychiatr, vol.36, pp.25-27, 2018.

A. Maubert, C. Hanon, and F. Sedel,

. Encephale, , vol.42, pp.208-221, 2016.

M. J. Fraidakis, Psychiatric manifestations in cerebrotendinous xanthomatosis. Transl Psychiatry, vol.3, p.302, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01595966

P. Zimbrean and J. Seniów, Cognitive and psychiatric symptoms in Wilson disease, Handb Clin Neurol, vol.142, pp.121-140, 2017.

D. Serata, D. Casale, A. Rapinesi, C. Mancinelli, I. Pompili et al., Hemochromatosis-induced bipolar disorder: a case report, Gen Hosp Psychiatry, 2012.

, , vol.34, pp.101-102

L. Duque-serrano, L. Patarroyo-rodriguez, D. Gotlib, and J. C. Molano-eslava, Psychiatric Aspects of Acute Porphyria: a Comprehensive Review Current Psychiatry Reports, vol.20, p.5, 2018.

G. M. Macqueen, P. I. Rosebush, and M. F. Mazurek, Neuropsychiatric aspects of the adult variant of Tay-Sachs disease, J Neuropsychiatry Clin Neurosci, vol.10, issue.1, pp.10-19, 1998.

S. Kölker, A. Garcia-cazorla, V. Valayannopoulos, A. M. Lund, A. B. Burlina et al.,

L. Meirleir, D. Dobbelaere, V. Dvorakova, F. Furlan, F. Gleich et al., The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation, J Inherit Metab Dis, vol.38, issue.6, pp.1155-1161, 2015.

S. J. Sacharow, J. D. Picker, and H. L. Levy, Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency, 2004.

M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. Bean et al., , 2017.

A. Gales, M. Masingue, and S. Millecamps, Adolescence/adult onset MTHFR deficiency may manifest as isolated and treatable distinct neuro-psychiatric syndromes, Orphanet Journal of Rare Diseases, vol.13, p.29, 2018.

D. A. Bilder, J. K. Noel, E. R. Baker, W. Irish, Y. Chen et al., Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria, Dev Neuropsychol, vol.41, issue.4, pp.245-260, 2016.

Y. Bar-yam, General Features of Complex Systems" (PDF), 2002.

H. C. Kraemer, E. Stice, A. Kazdin, D. Offord, and D. Kupfer, How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors, Am J Psychiatry, vol.158, issue.6, pp.848-56, 2001.

, Caisse Nationale d'Assurance Maladie -Améliorer la qualité du système de santé et maîtriser les dépenses -Rapport au ministre chargé de la Sécurité sociale et au Parlement sur l'évolution des charges et produits de l'Assurance Maladie au titre de 2019